Panchsheel Organics Limited (BOM:531726)

Market Cap	1.90B +15.6%
Revenue (ttm)	1.10B +2.9%
Net Income	108.30M -21.5%
EPS	8.22 -21.5%
Shares Out	13.17M
PE Ratio	17.52
Forward PE	n/a
Dividend	3.20 (2.22%)
Ex-Dividend Date	Feb 20, 2026

Volume	9,219
Open	145.15
Previous Close	144.10
Day's Range	142.00 - 148.95
52-Week Range	86.10 - 184.00
Beta	-0.04
Analysts	n/a
Price Target	n/a
Earnings Date	May 30, 2026

About Panchsheel Organics

Panchsheel Organics Limited engages in the manufacture and trading of bulk drugs and intermediates in India and internationally. It manufactures and exports active pharma ingredients (API), human and veterinary intermediates and finished formulations, specialty chemicals, hormones, steroids, etc. The company also offers a range of products in various categories, such as cardiovascular, neuropsychiatry, anti-fungal, fluoroquinolones, antiallergic, anti-inflammatory, gastrointestinal, osteoporosis, erectile dysfunction, and others. Panchsheel Org...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1989
• Employees: 185
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 531726

Financial Performance

In fiscal year 2026, Panchsheel Organics's revenue was 1.10 billion, an increase of 2.91% compared to the previous year's 1.07 billion. Earnings were 108.30 million, a decrease of -21.49%.